The Ki67 index, also known as a proliferation biomarker, is an independent prognostic factor in BC and it is used to evaluate the risk of recurrence and BC survival; higher Ki67 correlates with tumor grade and poor prognosis (32, 41–43). This evidence concerns the gene MKI67 and neoplasm.